Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Thursday Night Live: Putting the “I” Back in Team – Impella® Management in the ICU

Viktoriya Kagan, AGACNP-BC, CCRN, and Eddy Gutierrez, MD, discuss how to care for patients with cardiogenic shock and manage Impella® in the ICU.

ECMO and pMCS for Advanced Cardiogenic Shock

Prof. Dr. Evgenij V. Potapov discusses combining extracorporeal life support (ECLS) with pMCS for treating advanced cardiogenic shock.

Subanalysis of Women in IMP-IT Registry

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

ECpella Therapy

Jacob Abraham, MD, Raymond Lee, MD, and Bindu Akkanti, MD, discuss ECpella therapy in this CAMP webinar moderated by Misty Casseus, MSN, RN.

Renal Recovery in HFCS with Impella 5.5® with SmartAssist®

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

TCT 2022: Cardiogenic Shock Working Group and SCAI Shock Stages

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Moving the Needle in AMI Cardiogenic Shock Survival

William O’Neill, MD, discusses the need for designing programs to improve outcomes in patients with AMI cardiogenic shock.

 The Current State of MCS for AMICS  

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Building Collaboration Between Interventionalists and Cardiac Surgeons

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella.

Impella® Placement Pre-PCI for AMI Cardiogenic Shock  

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.

 

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

Data-Driven Point-of-Care Risk Model in Patients with AMICS

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

Eligibility for MCS Based on Cardiogenic Shock RCTs

Benedikt Schrage, MD, discusses his paper examining how enrollment criteria in RCTs apply to the real-world cardiogenic shock patient population.

HFSA 2021: Managing AMI Cardiogenic Shock Using the National Cardiogenic Shock Initiative Study Protocol

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].